• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

文拉法辛治疗的重性抑郁障碍患者认知功能与基于努力的决策表现之间的关系。

Association between cognitive function and performance on effort based decision making in patients with major depressive disorder treated with Vortioxetine.

机构信息

Mood Disorders Psychopharmacology Unit, University Health Network, Canada.

Mood Disorders Psychopharmacology Unit, University Health Network, Canada; University of Toronto, Canada.

出版信息

Compr Psychiatry. 2019 Oct;94:152113. doi: 10.1016/j.comppsych.2019.07.006. Epub 2019 Jul 24.

DOI:10.1016/j.comppsych.2019.07.006
PMID:31404802
Abstract

BACKGROUND

It is well established that deficits in motivation, reward, and cognition are common during and in between syndromal episodes of depression as part of Major Depressive Disorder (MDD). Informed by evidence indicating functional and structural interconnectivity between cognitive and reward brain circuits, we preliminarily evaluate the association between measures of cognitive performance and reward/motivation.

METHODS

This is a post-hoc analysis of a primary study (i.e. the THINC-it sensitivity to change study). Adults (18-65 years of age) meeting DSM-5 criteria for MDD, single-episode or recurrent confirmed by M.I.N.I. with moderate severity or greater (i.e. Montgomery Asberg Depression Rating Scale ≥20). All eligible subjects received vortioxetine 10-20 mg open-label for 8 weeks. The Effort Expenditure Reward Task (EEfRT) was the principal measure of motivation and reward. We directly compare the effects of cognitive measures and depressive symptoms on effort-based decision-making using the THINC-it composite score and MADRS total score.

RESULTS

Twenty-one participants with MDD (Mean age = 38.47, SD = 12.85) and 20 healthy volunteers (Mean age = 41.50, SD = 14.21) completed the optional EEfRT task. Amongst individuals with MDD, performance in processing speed, executive function (i.e. Trails B) and overall composite cognitive score was positively associated with the proportion of hard-task choices in the high reward condition (i.e. greater reward valuation). Across both groups, a greater probability (χ = 1.137) and magnitude of reward (χ = 0.045) was associated with increased effort (i.e. choosing the hard task more frequently). Using fully factored GEE models, we observed a positive association between performance on the Trails test (β = 2.223, SE = 0.928, p = 0.017) as well as the composite score (β = 0.978, SE = 0.0.459, p = 0.033), and greater effort for high rewards. In addition, it was observed that a positive association (i.e. greater effort for reward in higher probability) was observed with depressive symptoms and overall cognitive measures.

CONCLUSION

Herein, we observed that an association exists between overall cognitive function, notably processing speed and executive function and reward function. Specifically, a greater effort for hard task rewards (using the EEfRT task) was manifested in individuals exhibiting higher levels of cognitive performance in a well-characterized sample of MDD treated with Vortioxetine.

摘要

背景

已有研究证实,在抑郁症发作期间和发作之间,动机、奖励和认知方面的缺陷是常见的,这是重度抑郁症(MDD)的一部分。鉴于证据表明认知和奖励大脑回路之间存在功能和结构的相互连通性,我们初步评估了认知表现与奖励/动机之间的关联。

方法

这是一项主要研究(即 THINC-it 变化敏感性研究)的事后分析。符合 DSM-5 标准的 MDD 成人(18-65 岁),单次发作或复发,经 M.I.N.I. 确认,严重程度为中度或以上(即蒙哥马利抑郁评定量表[MADRS]≥20)。所有符合条件的患者接受为期 8 周的沃替西汀 10-20mg 开放标签治疗。努力支出奖励任务(EEfRT)是动机和奖励的主要测量方法。我们使用 THINC-it 综合评分和 MADRS 总分直接比较认知测量和抑郁症状对基于努力的决策的影响。

结果

21 名 MDD 患者(平均年龄 38.47,标准差 12.85)和 20 名健康志愿者(平均年龄 41.50,标准差 14.21)完成了可选的 EEfRT 任务。在 MDD 患者中,处理速度、执行功能(即 Trails B)和整体认知综合评分的表现与高奖励条件下困难任务选择的比例呈正相关(即更大的奖励估值)。在两组中,更大的概率(χ=1.137)和奖励幅度(χ=0.045)与更大的努力(即更频繁地选择困难任务)相关。使用完全因子广义估计方程模型,我们观察到 Trails 测试的表现(β=2.223,SE=0.928,p=0.017)以及综合评分(β=0.978,SE=0.0.459,p=0.033)与高奖励时的更大努力之间存在正相关关系。此外,还观察到与抑郁症状和整体认知测量一样,与奖励的正相关(即更高的奖励需要更大的努力)。

结论

在这里,我们观察到整体认知功能,特别是处理速度和执行功能与奖励功能之间存在关联。具体来说,在接受沃替西汀治疗的 MDD 特征明确的样本中,表现出更高认知水平的个体在使用 EEfRT 任务时表现出更高的努力,以获得更高难度任务的奖励。

相似文献

1
Association between cognitive function and performance on effort based decision making in patients with major depressive disorder treated with Vortioxetine.文拉法辛治疗的重性抑郁障碍患者认知功能与基于努力的决策表现之间的关系。
Compr Psychiatry. 2019 Oct;94:152113. doi: 10.1016/j.comppsych.2019.07.006. Epub 2019 Jul 24.
2
Effort-based decision-making is affected by overweight/obesity in major depressive disorder.基于努力的决策受重度抑郁症中超重/肥胖的影响。
J Affect Disord. 2019 Sep 1;256:221-227. doi: 10.1016/j.jad.2019.06.002. Epub 2019 Jun 4.
3
Motivational deficits in effort-based decision making in individuals with subsyndromal depression, first-episode and remitted depression patients.亚综合征抑郁、首发抑郁和缓解期抑郁患者基于努力的决策中动机不足。
Psychiatry Res. 2014 Dec 30;220(3):874-82. doi: 10.1016/j.psychres.2014.08.056. Epub 2014 Sep 16.
4
Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: A novel dual outcome measure in depressive disorders.伏硫西汀可改善重度抑郁症的症状和功能结局:一种用于抑郁症的新型双重结局指标。
J Affect Disord. 2018 Feb;227:787-794. doi: 10.1016/j.jad.2017.11.081. Epub 2017 Nov 16.
5
Diminished caudate and superior temporal gyrus responses to effort-based decision making in patients with first-episode major depressive disorder.首发重度抑郁症患者尾状核和颞上回对基于努力的决策反应减弱。
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:52-9. doi: 10.1016/j.pnpbp.2015.07.006. Epub 2015 Jul 18.
6
The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder.伏硫西汀对重度抑郁症患者快感缺失的疗效
Front Psychiatry. 2019 Jan 31;10:17. doi: 10.3389/fpsyt.2019.00017. eCollection 2019.
7
Cognitive-functional relationships in major depressive disorder: Crucial data from a Ukrainian open-label study of vortioxetine versus escitalopram.重性抑郁障碍的认知-功能关系:文拉法辛与艾司西酞普兰开放标签研究的关键数据来自乌克兰。
J Affect Disord. 2019 May 1;250:114-122. doi: 10.1016/j.jad.2019.03.040. Epub 2019 Mar 5.
8
Randomized, double-blind, placebo-controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder.一项评估沃替西汀治疗日本重度抑郁症患者的疗效和安全性的随机、双盲、安慰剂对照研究。
Psychiatry Clin Neurosci. 2020 Feb;74(2):140-148. doi: 10.1111/pcn.12956. Epub 2019 Dec 18.
9
Changes in sleep predict changes in depressive symptoms in depressed subjects receiving vortioxetine: An open-label clinical trial.接受文拉法辛治疗的抑郁患者中,睡眠变化可预测抑郁症状变化:一项开放标签临床试验。
J Psychopharmacol. 2019 Nov;33(11):1388-1394. doi: 10.1177/0269881119874485. Epub 2019 Sep 18.
10
Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia.重度抑郁症中的基于努力的决策:动机快感缺失的转化模型。
J Abnorm Psychol. 2012 Aug;121(3):553-8. doi: 10.1037/a0028813. Epub 2012 Jul 9.

引用本文的文献

1
Relationship of prefrontal cortex activity with anhedonia and cognitive function in major depressive disorder: an fNIRS study.前额叶皮层活动与重度抑郁症中快感缺乏及认知功能的关系:一项功能近红外光谱研究
Front Psychiatry. 2024 Sep 19;15:1428425. doi: 10.3389/fpsyt.2024.1428425. eCollection 2024.
2
Major Depression in Comorbidity with Substance use Disorders: Patients' Features and Clinical-Neurobiological Rationale of Antidepressant Treatments.合并物质使用障碍的重度抑郁症:患者特征及抗抑郁治疗的临床神经生物学原理
Curr Neuropharmacol. 2025;23(3):256-275. doi: 10.2174/1570159X22666240827165327.
3
Effectiveness of Vortioxetine for the Treatment of Emotional Blunting in Patients with Major Depressive Disorder Experiencing Inadequate Response to SSRI/SNRI Monotherapy in Spain: Results from the COMPLETE Study.
伏硫西汀治疗西班牙对SSRI/SNRI单药治疗反应不足的重度抑郁症患者情感迟钝的有效性:COMPLETE研究结果
Neuropsychiatr Dis Treat. 2024 Jul 30;20:1475-1489. doi: 10.2147/NDT.S473056. eCollection 2024.
4
The Effects of Fluoxetine and Agomelatine on Neurocognitive Functions and Sleep in Patients with Major Depressive Disorder.氟西汀和阿戈美拉汀对重度抑郁症患者神经认知功能及睡眠的影响
Psychiatry Clin Psychopharmacol. 2024 Mar 1;34(1):9-18. doi: 10.5152/pcp.2024.22498. eCollection 2024 Mar.
5
Sensitivity to intrinsic rewards is domain general and related to mental health.对内在奖励的敏感性具有领域普遍性,且与心理健康相关。
Nat Ment Health. 2023;1(9):679-691. doi: 10.1038/s44220-023-00116-x. Epub 2023 Sep 6.
6
Supraphysiologic doses of 17β-estradiol aggravate depression-like behaviors in ovariectomized mice possibly via regulating microglial responses and brain glycerophospholipid metabolism.超生理剂量的 17β-雌二醇可能通过调节小胶质细胞反应和脑甘油磷脂代谢加重去卵巢小鼠的抑郁样行为。
J Neuroinflammation. 2023 Sep 7;20(1):204. doi: 10.1186/s12974-023-02889-5.
7
Design of a real-world, prospective, longitudinal, observational study to compare vortioxetine with other standard of care antidepressant treatments in patients with major depressive disorder: a PatientsLikeMe survey.一项真实世界、前瞻性、纵向、观察性研究的设计,旨在比较伏硫西汀与其他标准抗抑郁药物治疗重度抑郁症患者的疗效:一项 PatientsLikeMe 调查。
BMC Psychiatry. 2023 Jun 26;23(1):464. doi: 10.1186/s12888-023-04922-6.
8
Associations Between Negative Symptoms and Effort Discounting in Patients With Schizophrenia and Major Depressive Disorder.精神分裂症和重度抑郁症患者的阴性症状与努力折扣之间的关联。
Schizophr Bull Open. 2021 Jun 11;2(1):sgab022. doi: 10.1093/schizbullopen/sgab022. eCollection 2021 Jan.
9
Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update.伏硫西汀——慢性神经性疼痛治疗的新前沿:综述与更新
Ther Adv Psychopharmacol. 2021 Sep 3;11:20451253211034320. doi: 10.1177/20451253211034320. eCollection 2021.
10
Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder.伏硫西汀治疗快感缺失的疗效:对重度抑郁症患者短期研究的汇总分析结果
Neuropsychiatr Dis Treat. 2021 Feb 22;17:575-585. doi: 10.2147/NDT.S296451. eCollection 2021.